Daratumumab (Anti-CD38) for Treatment of Disseminated Nontuberculous Mycobacteria in a Patient With Anti-Interferon-γ Autoantibodies

被引：30
|
作者：
Ochoa, Sebastian [1 ]
Ding, Li [1 ]
Kreuzburg, Samantha [1 ]
Treat, Jennifer [2 ]
Holland, Steven M. [1 ]
Zerbe, Christa S. [1 ]
机构：
[1] NIAID, Lab Clin Immunol & Microbiol, Div Intramural Res, NIH, Bethesda, MD 20892 USA
[2] Med Sci & Comp, Rockville, MD USA
来源：
CLINICAL INFECTIOUS DISEASES | 2021年 / 72卷 / 12期
基金：
美国国家卫生研究院;
关键词：
daratumumab; mycobacteria; disseminated; interferon gamma; autoantibodies;
D O I：
10.1093/cid/ciaa1086
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Patients with autoantibodies to interferon-gamma (IFN-gamma) may develop severe nontuberculous mycobacterial infections. We describe the novel use of daratumumab in a patient with autoantibodies to IFN-gamma who had progressive infection, resulting in clinical and radiographic improvement.
引用
收藏
页码：2206 / 2208
页数：3
相关论文
共 50 条
  • [31] Blood Transfusion Management for Patients Treated With Anti-CD38 Monoclonal Antibodies
    Lancman, Guido
    Arinsburg, Suzanne
    Jhang, Jeffrey
    Cho, Hearn Jay
    Jagannath, Sundar
    Madduri, Deepu
    Parekh, Samir
    Richter, Joshua
    Chari, Ajai
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [32] Risk of new alloimmunization in patients on anti-CD38 treatment using tube LISS-IAT method
    Stanic, Hana Safic
    Galic, Zrinka Kruhonja
    Lukic, Martina
    Bingulac-Popovic, Jasna
    Jukic, Irena
    TRANSFUSION AND APHERESIS SCIENCE, 2024, 63 (02)
  • [33] Rituximab Restores IFN-γ-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-γ Autoantibody
    Yusuke Koizumi
    Takuro Sakagami
    Naoya Nishiyama
    Jun Hirai
    Yuta Hayashi
    Nobuhiro Asai
    Yuka Yamagishi
    Hideo Kato
    Mao Hagihara
    Daisuke Sakanashi
    Hiroyuki Suematsu
    Kenji Ogawa
    Hiroshige Mikamo
    Journal of Clinical Immunology, 2017, 37 : 644 - 649
  • [34] HLA Desensitization in Solid Organ Transplantation: Anti-CD38 to Across the Immunological Barriers
    Joher, Nizar
    Matignon, Marie
    Grimbert, Philippe
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [35] Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab
    Lidicky, Ondrej
    Klener, Pavel
    Machova, Daniela
    Vockova, Petra
    Pokorna, Eva
    Helman, Karel
    Mavis, Cory
    Janouskova, Olga
    Etrych, Tomas
    JOURNAL OF CONTROLLED RELEASE, 2020, 328 (328) : 160 - 170
  • [36] EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma
    Chemlal, Djamila
    Varlet, Emmanuel
    Machura, Amelie
    Ovejero, Sara
    Requirand, Guilhem
    Robert, Nicolas
    Cartron, Guillaume
    Alaterre, Elina
    Bret, Caroline
    Vincent, Laure
    Herbaux, Charles
    Cavalli, Giacomo
    Bruyer, Angelique
    De Boussac, Hugues
    Moreaux, Jerome
    LEUKEMIA, 2023, 37 (9) : 1925 - 1928
  • [37] Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodies
    Costa, Luciano J.
    Gay, Francesca
    Landgren, Ola
    Mateos, Maria-Victoria
    Moreau, Philippe
    Touzeau, Cyrille
    Ertel, Franziska
    Mcfadden, Ian
    Najdi, Rani
    Weisel, Katja
    ANNALS OF HEMATOLOGY, 2025, : 1329 - 1351
  • [38] Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis
    Chiarenza, Decimo Silvio
    Mancini, Raul
    Bigatti, Carolina
    Caridi, Gianluca
    Consolaro, Alessandro
    Natoli, Valentina
    Mortari, Gabriele
    Kajana, Xhuliana
    Lugani, Francesca
    Gattorno, Marco
    Ghiggeri, Gian Marco
    La Porta, Edoardo
    Gaggero, Gabriele
    Verrina, Enrico E.
    Angeletti, Andrea
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [39] Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients
    Pavon, Esther J.
    Zumaquero, Esther
    Rosal-Vela, Antonio
    Khoo, Keng-Meng
    Cerezo-Wallis, Daniela
    Garcia-Rodriguez, Sonia
    Carrascal, Montserrat
    Abian, Joaquin
    Graeff, Richard
    Callejas-Rubio, Jose-Luis
    Ortego-Centeno, Norberto
    Malavasi, Fabio
    Zubiaur, Mercedes
    Sancho, Jaime
    CYTOKINE, 2013, 62 (02) : 232 - 243
  • [40] Pharmacy considerations: Use of anti-CD38 monoclonal antibodies in relapsed and/or refractory multiple myeloma
    Shah, Bhavesh
    Gray, Joy
    Abraham, Ivo
    Chang, Melody
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2023, 29 (01) : 170 - 182
12345